摘要
本文通过对心衰患者的生存率、致残率、死亡率的叙述,分别从中西医两个观点来阐述了近年来心衰的病因病机、病理生理及治疗等方面的进展。说明心衰的治疗不止是改善症状,更重要的是提高患者生活质量、提高生存率,从而降低住院率及死亡率;从生物学角度来讲,就是从注重改善血流动力学、液体潴留机制,逐渐转变为延缓心肌重构的机制。预防与治疗并重。突出了中医治疗心衰的优势。
This article through to the survival rates of patients with heart failure, morbidity, and mortality of narrative, respectively from two perspectives expounds the Chinese and western medicine in recent years the etiology and pathogenesis, pathology, physiology and treatment of heart failure and other aspects of progress. Treatment is not only to improve symptoms of heart failure, more important is to improve the patients＇ quality of life, improve the survival rate, thus reducing hospitalization rate and mortality rate.ln the aspect of biology, from pay attention to improve hemodynamics and fluid retention mechanism, gradually transition to the mechanism of delay myocardial remodeling.Pay equal attention to prevention and treatment, highlighting the advantages of traditional Chinese medicine treatment for heart failure.
出处
《中国医学创新》
CAS
2016年第26期140-144,共5页
Medical Innovation of China
关键词
慢性心力衰竭
病理生理
病因病机
中西医治疗
Chronic heart failure
Pathology and physiology
Etiology and pathogenesis
Chineseand western medicine treatment
